drugset / Trial / NCT01748695
A Safety, Tolerability and Efficacy Study of V158866 in Central Neuropathic Pain Following Spinal Cord Injury
RandomizedCrossoverDouble-blindTreatment
Summary
The purpose of this study is to investigate whether V158866 is safe and effective for the treatment of neuropathic pain due to spinal cord injury.
Timeline
- Start
- 2013-06
- Primary completion
- 2015-07
- Completion
- 2015-07
Outcome
Missed primary endpoint
registry analysis (superiority or other test); Placebo vs V158866; p = 0.834 NCT01748695 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | V158866 | Unknown | 450 mg | — |
Indications
No indication recorded.